logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

GOLD PEAK (00040) will distribute a mid-year dividend of 1.8 Hong Kong cents per share on January 8.

date
19:12 20/11/2025
avatar
GMT Eight
Kingsoft Corporation (stock code: 00040) announced that it will distribute an interim dividend of HK$0.18 per share on January 8, 2026.
GOLD PEAK (00040) announced that it will distribute a mid-year dividend of 1.8 Hong Kong cents per share on January 8, 2026.
Related Articles
China Stock
Ligeance Aerospace Technology (000697.SZ): All restructuring investors have fully paid the restructuring investment funds.
US Stock
Johnson & Johnson (JNJ.US) has applied for its first-in-class new drug to be marketed domestically in China, and the Center for Drug Evaluation (CDE) has included it in the list for priority review.
US Stock
Comprehensive Customer Strategy + E-commerce Business Boost Walmart Inc. (WMT.US) Q3 Earnings Exceed Expectations Once Again, Raising Full-Year Performance Guidance
Ligeance Aerospace Technology (000697.SZ): All restructuring investors have fully paid the restructuring investment funds.
China Stock
Johnson & Johnson (JNJ.US) has applied for its first-in-class new drug to be marketed domestically in China, and the Center for Drug Evaluation (CDE) has included it in the list for priority review.
US Stock
Comprehensive Customer Strategy + E-commerce Business Boost Walmart Inc. (WMT.US) Q3 Earnings Exceed Expectations Once Again, Raising Full-Year Performance Guidance
US Stock
RECOMMEND
Tech Stocks, Crypto, and Gold Slump; U.S. Equities Break Key Support Amid Broad-based Sell-off
Tech Stocks, Crypto, and Gold Slump; U.S. Equities Break Key Support Amid Broad-based Sell-off
icon
18/11/2025
Goldman Sachs’ Ten-year Investment Outlook: Artificial Intelligence and Emerging Markets As Core Growth Engines
Goldman Sachs’ Ten-year Investment Outlook: Artificial Intelligence and Emerging Markets As Core Growth Engines
icon
18/11/2025
Consensus On Multiple Outcomes, Easing Trade Tensions, China–Germany High-level Financial Dialogue Convened In Beijing
Consensus On Multiple Outcomes, Easing Trade Tensions, China–Germany High-level Financial Dialogue Convened In Beijing
icon
18/11/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.